Evidence map›Paper›PMID 35642014›Full record

ReviewActa neuropathologica communications2022

The polyG diseases: a new disease entity.

Tongling Liufu, Yilei Zheng, Jiaxi Yu, Yun Yuan, Zhaoxia Wang, Jianwen Deng, Daojun Hong

Open access · goldAbstract readReview
In one paragraph

Review in Acta neuropathologica communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Structural Polymorphism of polyG Inclusions Revealed by In Situ Cryo-Electron Tomography.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Encephalitis-like episodes with cortical edema and enhancement in patients with neuronal intranuclear inclusion disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Abnormal phase separation of biomacromolecules in human diseases.Acta biochimica et biophysica Sinica · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tongling Liufu *Department of Neurology, Peking University First Hospital, Beijing, China.
Yilei Zheng *Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Jiaxi YuDepartment of Neurology, Peking University First Hospital, Beijing, China.
Yun YuanDepartment of Neurology, Peking University First Hospital, Beijing, China.
Zhaoxia WangDepartment of Neurology, Peking University First Hospital, Beijing, China.
Jianwen DengDepartment of Neurology, Peking University First Hospital, Beijing, China. jianwendeng@pkufh.com.
Daojun HongDepartment of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China. hongdaojun@hotmail.com.
Peking University First Hospital · CNNanchang University · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, inspired by the similar clinical and pathological features shared with fragile X-associated tremor/ataxia syndrome (FXTAS), abnormal expansion of CGG repeats in the 5' untranslated region has been found in neuronal intranuclear inclusion disease (NIID), oculopharyngeal myopathy with leukoencephalopathy (OPML), and oculopharyngodistal myopathy (OPDMs). Although the upstream open reading frame has not been elucidated in OPML and OPDMs, polyglycine (polyG) translated by expanded CGG repeats is reported to be as a primary pathogenesis in FXTAS and NIID. Collectively, these findings indicate a new disease entity, the polyG diseases. In this review, we state the common clinical manifestations, pathological features, mechanisms, and potential therapies in these diseases, and provide preliminary opinions about future research in polyG diseases.

Indexed as

Fragile X Messenger Ribonucleoprotein 1Fragile X SyndromeAtaxiaHumansIntranuclear Inclusion BodiesMuscular DystrophiesNeurodegenerative DiseasesPeptidesTremorFragile X Messenger Ribonucleoprotein 1PeptidespolyglycineFragile X-associated tremor/ataxia syndromeNeuronal intranuclear inclusion diseaseOculopharyngeal myopathy with leukoencephalopathyOculopharyngodistal myopathyPolyG diseases

Identifiers

PMID35642014
PMCPMC9153130
OpenAlexW4281762795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.